At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
TCS ADD ™ Platforms / Article
Hilde Vanaken
Senior Industry Advisor, TCS Life Sciences and Healthcare
Priyanka Sawant
Head, TCS ADD Patient and Site Engagement
You have these already downloaded
We have sent you a copy of the report to your email again.
The COVID-19 pandemic has stalled multiple businesses and processes across the globe including clinical trials since there are critical activities that are carried out on site in-person such as informed consent. The impact is not just seen for new patients but also for existing patients who are required to provide re-consents in accordance with the COVID-19-led changes. To overcome these challenges, an expedited introduction and onboarding of an electronic consenting tool could be a solution. The virtual approach will enable sites to connect with patients without the need for in-person visits. This paper explores digital/virtual approaches to informed consent that could reinstate clinical trials and proceeds to study real-life implementation that Roche has executed to solve its remote consenting challenges for COVID-19 impacted clinical trials.
TCS ADD™ Clinical Data Repository
Streamlining Medical Literature Analysis via AI and Generative AI
AI in Pharmacovigilance – Accelerating Innovation
AR/VR Revolutionizing Clinical Trial Monitoring and Data Analysis